Protagonist Therapeutics Inc (PTGX)
Free Cash Flow
$218.88M
Quarterly · Period ending: · USD
PTGX Free Cash Flow
Latest reported$218.88Mperiod ending
Latest reported$218.88Mperiod ending
PTGX Quarterly Free Cash Flow (-$2.44M → $218.88M)
Quarterly free cash flow
High-resolution chart · PNG
PTGX free cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Free Cash Flow (USD) |
|---|---|
| 218,884,000 | |
| -49,158,000 | |
| -35,529,000 | |
| -2,025,000 | |
| -29,593,000 | |
| 124,818,000 | |
| -29,488,000 | |
| -28,638,000 | |
| 268,594,000 | |
| -27,671,000 | |
| 16,941,000 | |
| -27,015,000 | |
| -26,414,000 | |
| -34,357,000 | |
| -31,705,000 | |
| -25,363,000 | |
| -13,925,000 | |
| -37,939,000 | |
| -27,135,000 | |
| -28,735,000 | |
| -24,200,000 | |
| -28,896,000 | |
| -18,992,000 | |
| -16,362,000 | |
| -21,615,000 | |
| -15,986,000 | |
| -14,507,000 | |
| -13,937,000 | |
| 2,778,000 | |
| -16,828,000 | |
| -10,197,000 | |
| -9,424,000 | |
| -15,466,000 | |
| -15,346,000 | |
| -14,205,000 | |
| 40,514,000 | |
| -12,699,000 | |
| -10,404,000 | |
| -9,732,000 | |
| -7,028,000 | |
| -8,101,000 | |
| -5,490,000 | |
| -4,959,000 | |
| -3,882,000 | |
| -3,505,000 | |
| -2,438,000 |